CINCINNATI--(BUSINESS WIRE)--Girindus America, Inc., a service provider to the pharmaceutical industry and a leading manufacturer of therapeutic oligonucleotides, is pleased to announce that Mr. David Kennedy has joined Girindus as Director of Operations. Mr. Kennedy will report directly to Dr. F. Mark Laskovics, President and COO. Mr. Kennedy will lead the Oligonucleotide, Small Molecule and Radiochemistry operations. Mr. Kennedy brings to Girindus 30 years of Active Pharmaceutical Ingredient (API) production experience in both the process validation and commercial manufacturing areas. ‘We are very pleased to have someone of David’s caliber and experience level leading our Operations Team’, said Dr. Laskovics. ‘David’s addition enforces Girindus’ technical competence and capability to develop and execute commercial manufacturing programs.’
